Ameritas Investment Partners’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,385
| Closed | -$13.5K | – | 3170 |
|
|
2025
Q3 | $13.5K | Hold |
2,385
| – | – | ﹤0.01% | 2851 |
|
|
2025
Q2 | $9.09K | Hold |
2,385
| – | – | ﹤0.01% | 3008 |
|
|
2025
Q1 | $6.27K | Hold |
2,385
| – | – | ﹤0.01% | 2926 |
|
|
2024
Q4 | $8.44K | Hold |
2,385
| – | – | ﹤0.01% | 2944 |
|
|
2024
Q3 | $10.9K | Hold |
2,385
| – | – | ﹤0.01% | 2892 |
|
|
2024
Q2 | $10.4K | Hold |
2,385
| – | – | ﹤0.01% | 2914 |
|
|
2024
Q1 | $12K | Hold |
2,385
| – | – | ﹤0.01% | 2769 |
|
|
2023
Q4 | $15K | Hold |
2,385
| – | – | ﹤0.01% | 2711 |
|
|
2023
Q3 | $17K | Hold |
2,385
| – | – | ﹤0.01% | 2614 |
|
|
2023
Q2 | $24.3K | Buy |
+2,385
| New | +$24.9K | ﹤0.01% | 2464 |
|
|
2021
Q2 | – | Sell |
-475
| Closed | -$3K | – | 3209 |
|
|
2021
Q1 | $3K | Hold |
475
| – | – | ﹤0.01% | 3061 |
|
|
2020
Q4 | $3K | Hold |
475
| – | – | ﹤0.01% | 3031 |
|
|
2020
Q3 | $4K | Hold |
475
| – | – | ﹤0.01% | 3017 |
|
|
2020
Q2 | $3K | Buy |
+475
| New | +$4.17K | ﹤0.01% | 3025 |
|
|
2019
Q2 | – | Sell |
-625
| Closed | -$2K | – | 3101 |
|
|
2019
Q1 | $2K | Hold |
625
| – | – | ﹤0.01% | 2953 |
|
|
2018
Q4 | $2K | Hold |
625
| – | – | ﹤0.01% | 2958 |
|
|
2018
Q3 | $4K | Hold |
625
| – | – | ﹤0.01% | 2970 |
|
|
2018
Q2 | $4K | Hold |
625
| – | – | ﹤0.01% | 2956 |
|
|
2018
Q1 | $8K | Buy |
+625
| New | +$8.4K | ﹤0.01% | 2790 |
|
Ameritas Investment Partners's SCPH Position: Q4 2025 in Review
Ameritas Investment Partners sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 2,385 shares — an estimated $13.5K sold.
Ameritas Investment Partners first reported a position in SCPH in Q1 2018 and held it in 19 quarters. The position peaked at $24.3K in Q2 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Ameritas Investment Partners reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 2,385 scPharmaceuticals shares in Q4 2025, an estimated $13.5K.
- Ameritas Investment Partners first reported a position in scPharmaceuticals in Q1 2018 and held it in 19 quarters.
- Ameritas Investment Partners's scPharmaceuticals position peaked at $24.3K in Q2 2023.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.